Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management (Q34648346)

From Wikidata

Revision as of 23:32, 6 May 2022 by Simon Villeneuve (talk | contribs) (‎Updated Item: Author Disambiguator set author Emil Skamene (Q3052239) (details))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published in March 2003

Language	Label	Description	Also known as
English	Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management	scientific article published in March 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

0 references

5

object named as

Emil Skamene

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Michael A Gardam

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Edward C Keystone

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Richard Menzies

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Steven Manners

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Richard Long

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Donald C Vinh

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

148-155

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cytokines in the immune response to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor: biology and therapeutic inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Restraining mycobacteria: role of granulomas in mycobacterial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor Necrosis Factor in the Malnutrition (Cachexia) of Infection and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for lymphotoxin β receptor in host defense againstMycobacterium bovis BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept therapy in children with treatment-resistant uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroids in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900545-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(03)00545-0

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34648346&oldid=1633555855"